Survivin (BIRC5) cell cycle computational network in human no-tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation

Journal of Cellular Biochemistry

Volumn 112, Issue 5, 2011, Pages 1286-1294

  Wang, Lin ^a   Huang, Juxiang ^a   Jiang, Minghu ^b   Sun, Lingjun ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

cell cycle; human hepatocellular carcinoma; no tumor hepatitis cirrhosis; survivin (BIRC5) computational network

Indexed keywords

AMINO ACID; AURORA B KINASE; BIRC5 PROTEIN; BIRC6 PROTEIN; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; CASPASE 3; CASPASE 7; CASPASE 9; CDCA8 PROTEIN; CELL CYCLE PROTEIN 2; CELL CYCLE PROTEIN 20; CYCLIN DEPENDENT KINASE 4; EXPORTIN 1; HEAT SHOCK PROTEIN 90SS2; INCENP PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; NEK2 PROTEIN; PHOSPHOPROTEIN PHOSPHATASE; PPP1CC PROTEIN; RASA1 PROTEIN; RNA POLYMERASE II; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; SURVIVIN; TRANSCRIPTION FACTOR; TUBG1 PROTEIN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; UPSTREAM STIMULATORY FACTOR 2; X LINKED INHIBITOR OF APOPTOSIS;

ARTICLE; CELL COUNT; CELL CYCLE; CELL DIVISION; CELL GROWTH; CELL NUCLEUS; CELL VOLUME; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE REGULATORY NETWORK; GENETIC ALGORITHM; GENETIC DATABASE; HEPATITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MALIGNANT TRANSFORMATION; MITOSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; RNA TRANSCRIPTION; SYSTEM ANALYSIS;

ALGORITHMS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; DATABASES, GENETIC; GENE REGULATORY NETWORKS; HEPATITIS B; HEPATITIS C; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MODELS, GENETIC;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 79953713241     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23030     Document Type: Article

References (46)

1. Adhikari JS, Dwarakanath BS, Mathur R, Ravindranath T,. 2003. Alterations in radiation induced cell cycle perturbations by 2-deoxy- D- glucose in human tumor cell lines. Indian J Exp Biol 41: 1392-1399. (Pubitemid 37506934)
2. Andersen MH, Thor SP,. 2002. Survivin-A universal tumor antigen. Histol Histopathol 17: 669-675.
3. Aqui NA, Vonderheide RH,. 2008. Survivin as a universal tumor antigen for novel cancer immunotherapy: Functions of a killer clone. Cancer Biol Ther 7: 1888-1889.
4. Arlt D, Huber W, Liebel U, Schmidt C, Majety M, Sauermann M, Rosenfelder H, Bechtel S, Mehrle A, Bannasch D, Schupp I, Seiler M, Simpson JC, Hahne F, Moosmayer P, Ruschhaupt M, Guilleaume B, Wellenreuther R, Pepperkok R, Sultmann H, Poustka A, Wiemann S,. 2005. Functional profiling: From microarrays via cell-based assays to novel tumor relevant modulators of the cell cycle. Cancer Res 65: 7733-7742. (Pubitemid 41297248)
5. Braun K, Ehemann V, Waldeck W, Pipkorn R, Corban-Wilhelm H, Jenne J, Gissmann L, Debus J,. 2004. HPV18 E6 and E7 genes affect cell cycle, pRB and p53 of cervical tumor cells and represent prominent candidates for intervention by use peptide nucleic acids (PNAs). Cancer Lett 209: 37-49. (Pubitemid 38625743)
6. Cheng T,. 2004. Cell cycle inhibitors in normal and tumor stem cells. Oncogene 23: 7256-7266. (Pubitemid 39382159)
7. Cheung AK, Lung HL, Hung SC, Law EW, Cheng Y, Yau WL, Bangarusamy DK, Miller LD, Liu ET, Shao JY, Kou CW, Chua D, Zabarovsky ER, Tsao SW, Stanbridge EJ, Lung ML,. 2008. Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma. Cancer Res 68: 8137-8145.
8. Choudhury AD, Xu H, Baer R,. 2004. Ubiquitination and proteasomal degradation of the BRCA1 tumor suppressor is regulated during cell cycle progression. J Biol Chem 279: 33909-33918. (Pubitemid 39063041)
9. Dou QP, Smith DM, Daniel KG, Kazi A,. 2003. Interruption of tumor cell cycle progression through proteasome inhibition: Implications for cancer therapy. Prog Cell Cycle Res 5: 441-446.
10. Fey MF,. 2000. [Cell cycle and cancer-From the tumor cell line to the patient]. Praxis (Bern 1994) 89: 435-437.
11. Graf F, Koehler L, Kniess T, Wuest F, Mosch B, Pietzsch J,. 2009. Cell cycle regulating kinase Cdk4 as a potential target for tumor cell treatment and tumor imaging. J Oncol 2009: 106378.
12. Guha M, Altieri DC,. 2009. Survivin as a global target of intrinsic tumor suppression networks. Cell Cycle 8: 2708-2710.
13. Helt AM, Funk JO, Galloway DA,. 2002. Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells. J Virol 76: 10559-10568.
14. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J, Reich M, Chan JA, Glickman JN, Ikeda K, Hashimoto M, Watanabe G, Daidone MG, Roayaie S, Schwartz M, Thung S, Salvesen HB, Gabriel S, Mazzaferro V, Bruix J, Friedman SL, Kumada H, Llovet JM, Golub TR,. 2008. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 359: 1995-2004.
15. Huang J, Wang L, Jiang M, Zheng X,. 2010a. Interferon α-inducible protein 27 computational network construction and comparison between the frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients. Open Genomics J 3: 1-8.
16. Huang JX, Wang L, Jiang MH,. 2010b. TNFRSF11B computational development network construction and analysis between frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients. J Inflamm (Lond) 7: 50.
17. Kim DY, Martin CB, Lee SN, Martin BK,. 2005. Expression of complement protein C5a in a murine mammary cancer model: Tumor regression by interference with the cell cycle. Cancer Immunol Immunother 54: 1026-1037. (Pubitemid 41187711)
18. Konduri S, Colon J, Baker CH, Safe S, Abbruzzese JL, Abudayyeh A, Basha MR, Abdelrahim M,. 2009. Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression. Mol Cancer Ther 8: 533-542.
19. Kuntzen C, Sonuc N, De Toni EN, Opelz C, Mucha SR, Gerbes AL, Eichhorst ST,. 2005. Inhibition of c-Jun-N-terminal-kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest. Cancer Res 65: 6780-6788. (Pubitemid 41060716)
20. Liang QC, Xiong H, Zhao ZW, Jia D, Li WX, Qin HZ, Deng JP, Gao L, Zhang H, Gao GD,. 2009. Inhibition of transcription factor STAT5b suppresses proliferation, induces G1 cell cycle arrest and reduces tumor cell invasion in human glioblastoma multiform cells. Cancer Lett 273: 164-171.
21. Mhawech P, Greloz V, Oppikofer C, Szalay-Quinodoz I, Herrmann F,. 2004. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression. Cancer 100: 2367-2375. (Pubitemid 38657884)
22. Okada E, Murai Y, Matsui K, Isizawa S, Cheng C, Masuda M, Takano Y,. 2001. Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett 163: 109-116. (Pubitemid 32121836)
23. Patino-Garcia A, Pineiro ES, Diez MZ, Iturriagagoitia LG, Klussmann FA, Ariznabarreta LS,. 2003. Genetic and epigenetic alterations of the cell cycle regulators and tumor suppressor genes in pediatric osteosarcomas. J Pediatr Hematol Oncol 25: 362-367. (Pubitemid 36569966)
24. Pham NA, Jacobberger JW, Schimmer AD, Cao P, Gronda M, Hedley DW,. 2004. The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice. Mol Cancer Ther 3: 1239-1248. (Pubitemid 39440169)
25. Schoonjans K, Dubuquoy L, Mebis J, Fayard E, Wendling O, Haby C, Geboes K, Auwerx J,. 2005. Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation. Proc Natl Acad Sci USA 102: 2058-2062. (Pubitemid 40262011)
26. Schwartz TR, Vasta CA, Bauer TL, Parekh-Olmedo H, Kmiec EB,. 2008. G-rich oligonucleotides alter cell cycle progression and induce apoptosis specifically in OE19 esophageal tumor cells. Oligonucleotides 18: 51-63.
27. Sotillo R, Renner O, Dubus P, Ruiz-Cabello J, Martin-Caballero J, Barbacid M, Carnero A, Malumbres M,. 2005. Cooperation between Cdk4 and p27kip1 in tumor development: A preclinical model to evaluate cell cycle inhibitors with therapeutic activity. Cancer Res 65: 3846-3852. (Pubitemid 40616365)
28. Stewart CJ, Crook ML, Leung YC, Platten M,. 2009. Expression of cell cycle regulatory proteins in endometrial adenocarcinoma: Variations in conventional tumor areas and in microcystic, elongated and fragmented glands. Mod Pathol 22: 725-733.
29. Storey JD,. 2002. A direct approach to false discovery rates. J Roy Stat Soc, Ser B 64: 479-498.
30. Sun Y, Lin R, Dai J, Jin D, Wang SQ,. 2006. Suppression of tumor growth using antisense oligonucleotide against survivin in an orthotopic transplant model of human hepatocellular carcinoma in nude mice. Oligonucleotides 16: 365-374. (Pubitemid 46043155)
31. Sun Y, Wang L, Lui L,. 2008. Integrative decomposition procedure and Kappa statistics set up ATF2 ion binding module in Malignant Pleural Mesothelioma (MPM). Front Electr Electr Eng Chin 3: 381-387.
32. Sun Y, Wang L, Jiang M, Huang J, Liu Z, Wolfl S,. 2009. Secreted phosphoprotein 1 upstream invasive network construction and analysis of lung adenocarcinoma compared with human normal adjacent tissues by integrative biocomputation. Cell Biochem Biophys 56: 59-71.
33. Turovets NA, Agapova LS, Kopnin PB, Tulina NM, Chumakov PM, Kopnin BP,. 2000. [Effect of inactivating the p33ING1 tumor suppressor on the function of cell cycle "checkpoints" and genome stability]. Genetika 36: 385-392.
34. van der Veen AH, ten Hagen TL, Seynhaeve AL, Eggermont AM,. 2002. Lack of cell-cycle specific effects of tumor necrosis factor-alpha on tumor cells in vitro: Implications for combination tumor therapy with doxorubicin. Cancer Invest 20: 499-508. (Pubitemid 34686346)
35. Wang Y, Joshi T, Zhang XS, Xu D, Chen L,. 2006. Inferring gene regulatory networks from multiple microarray datasets. Bioinformatics 22: 2413-2420. (Pubitemid 44566971)
36. Wang L, Sun Y, Jiang M, Zhang S, Wolfl S,. 2009a. FOS proliferating network construction in early colorectal cancer (CRC) based on integrative significant function cluster and inferring analysis. Cancer Invest 27: 816-824.
37. Wang L, Sun Y, Jiang M, Zheng X,. 2009b. Integrative decomposition procedure and Kappa statistics for the distinguished single molecular network construction and analysis. J Biomed Biotechnol 2009: 726-728.
38. Wang L, Huang J, Jiang M,. 2010a. CREB5 computational regulation network construction and analysis between frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients. Cell Biochem Biophys [Epub ahead of print].
39. Wang L, Huang J, Jiang M,. 2010b. RRM2 computational phosphoprotein network construction and analysis between no-tumor hepatitis/cirrhotic liver tissues and human hepatocellular carcinoma (HCC). Cell Physiol Biochem 26: 303-310.
40. Wang L, Huang J, Jiang M, Sun L,. 2010c. MYBPC1 computational phosphoprotein network construction and analysis between frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients. Cell Mol Neurobiol [Epub ahead of print].
41. Wang L, Huang J, Jiang M, Zheng X,. 2010d. AFP computational secreted network construction and analysis between human hepatocellular carcinoma (HCC) and no-tumor hepatitis/cirrhotic liver tissues. Tumour Biol 31: 417-425.
42. Warrener R, Beamish H, Burgess A, Waterhouse NJ, Giles N, Fairlie D, Gabrielli B,. 2003. Tumor cell-selective cytotoxicity by targeting cell cycle checkpoints. Faseb J 17: 1550-1552.
43. Xia F, Canovas PM, Guadagno TM, Altieri DC,. 2008. A survivin-ran complex regulates spindle formation in tumor cells. Mol Cell Biol 28: 5299-5311.
44. Xiong H, Zhang ZG, Tian XQ, Sun DF, Liang QC, Zhang YJ, Lu R, Chen YX, Fang JY,. 2008. Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. Neoplasia 10: 287-297. (Pubitemid 351328587)
45. Xu X, Qiao W, Linke SP, Cao L, Li WM, Furth PA, Harris CC, Deng CX,. 2001. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Nat Genet 28: 266-271. (Pubitemid 32626030)
46. Zolochevska O, Figueiredo ML,. 2009. Expression of cell cycle regulator cdk2ap1 suppresses tumor cell phenotype by non-cell-autonomous mechanisms. Oral Oncol 45: e106-e112.